Display options
Cite
Pereira JC, Ramos TD, Silva JD, et al. Effects of Bone Marrow Mesenchymal Stromal Cell Therapy in Experimental Cutaneous Leishmaniasis in BALB/c Mice Induced by . Front Immunol. 2017;8:893doi: 10.3389/fimmu.2017.00893.
Pereira, J. C., Ramos, T. D., Silva, J. D., de Mello, M. F., Pratti, J. E. S., da Fonseca-Martins, A. M., Firmino-Cruz, L., Kitoko, J. Z., Chaves, S. P., Gomes, D. C. O., Diaz, B. L., Rocco, P. R. M., & de Matos Guedes, H. L. (2017). Effects of Bone Marrow Mesenchymal Stromal Cell Therapy in Experimental Cutaneous Leishmaniasis in BALB/c Mice Induced by . Frontiers in immunology, 8893. https://doi.org/10.3389/fimmu.2017.00893
Pereira, Joyce Carvalho, et al. "Effects of Bone Marrow Mesenchymal Stromal Cell Therapy in Experimental Cutaneous Leishmaniasis in BALB/c Mice Induced by ." Frontiers in immunology vol. 8 (2017): 893. doi: https://doi.org/10.3389/fimmu.2017.00893
Pereira JC, Ramos TD, Silva JD, de Mello MF, Pratti JES, da Fonseca-Martins AM, Firmino-Cruz L, Kitoko JZ, Chaves SP, Gomes DCO, Diaz BL, Rocco PRM, de Matos Guedes HL. Effects of Bone Marrow Mesenchymal Stromal Cell Therapy in Experimental Cutaneous Leishmaniasis in BALB/c Mice Induced by . Front Immunol. 2017 Aug 10;8:893. doi: 10.3389/fimmu.2017.00893. eCollection 2017. PMID: 28848541; PMCID: PMC5554126.
Copy Download .nbib Format: NLM
Share it on

Front Immunol. 2017 Aug 10;8:893. doi: 10.3389/fimmu.2017.00893. eCollection 2017.

Effects of Bone Marrow Mesenchymal Stromal Cell Therapy in Experimental Cutaneous Leishmaniasis in BALB/c Mice Induced by .

Frontiers in immunology

Joyce Carvalho Pereira, Tadeu Diniz Ramos, Johnatas Dutra Silva, Mirian França de Mello, Juliana Elena Silveira Pratti, Alessandra Marcia da Fonseca-Martins, Luan Firmino-Cruz, Jamil Zola Kitoko, Suzana Passos Chaves, Daniel Claudio De Oliveira Gomes, Bruno Lourenço Diaz, Patricia R M Rocco, Herbert Leonel de Matos Guedes

Affiliations

  1. Laboratório de Inflamação, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
  2. Laboratório de Investigação Pulmonar, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
  3. Laboratório Integrado de Imunoparasitologia, Campus Macaé - Universidade Federal do Rio de Janeiro, Macaé, Brazil.
  4. Laboratório de Imunobiologia, Núcleo de Doenças Infecciosas/Núcleo de Biotecnologia, Universidade Federal do Espírito Santo, Vitória, Brazil.
  5. Núcleo Multidisciplinar de Pesquisa UFRJ - Xerém em Biologia (NUMPEX-BIO), Polo Avançado de Xerém - Universidade Federal do Rio de Janeiro, Duque de Caxias, Brazil.
  6. Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.

PMID: 28848541 PMCID: PMC5554126 DOI: 10.3389/fimmu.2017.00893

Abstract

Cutaneous leishmaniasis remains both a public health and a therapeutic challenge. To date, no ideal therapy for cutaneous leishmaniasis has been identified, and no universally accepted therapeutic regimen and approved vaccines are available. Due to the mesenchymal stromal cell (MSC) immunomodulatory capacity, they have been applied in a wide variety of disorders, including infectious, inflammatory, and allergic diseases. We evaluated the potential effects of bone marrow MSC therapy in a murine model of cutaneous leishmaniasis.

Keywords: BALB/c; IL-10; Leishmania amazonensis; Leishmaniasis; cell therapy; mesenchymal stromal cell

References

  1. Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10344-9 - PubMed
  2. Stem Cell Res Ther. 2011 Aug 11;2(4):34 - PubMed
  3. J Immunol. 1997 Jun 1;158(11):5374-83 - PubMed
  4. Infect Immun. 2015 Apr;83(4):1366-71 - PubMed
  5. Infect Immun. 2003 Aug;71(8):4278-88 - PubMed
  6. Br J Haematol. 2003 Nov;123(4):702-11 - PubMed
  7. J Infect Dis. 1999 Nov;180(5):1731-4 - PubMed
  8. J Infect Dis. 2008 Feb 15;197(4):544-7 - PubMed
  9. Stem Cell Res Ther. 2016 Apr 14;7(1):53 - PubMed
  10. Infect Immun. 2003 Jun;71(6):3172-82 - PubMed
  11. Parasite Immunol. 2009 Aug;31(8):423-31 - PubMed
  12. Am J Trop Med Hyg. 1991 May;44(5):536-46 - PubMed
  13. Parasit Vectors. 2014 Sep 19;7:448 - PubMed
  14. Haematologica. 2005 Apr;90(4):516-25 - PubMed
  15. Exp Biol Med (Maywood). 2012 May;237(5):585-92 - PubMed
  16. Am J Respir Crit Care Med. 2010 Oct 15;182(8):1047-57 - PubMed
  17. Nat Immunol. 2003 Jan;4(1):10-1 - PubMed
  18. Vet Parasitol. 2008 Dec 20;158(4):239-55 - PubMed
  19. Am J Pathol. 2004 Feb;164(2):441-7 - PubMed
  20. Exp Hematol. 2008 Mar;36(3):309-18 - PubMed
  21. Cytotherapy. 2006;8(4):315-7 - PubMed
  22. Nat Rev Mol Cell Biol. 2011 Feb;12 (2):126-31 - PubMed
  23. Expert Opin Biol Ther. 2016 Nov;16(11):1353-1360 - PubMed
  24. PLoS Negl Trop Dis. 2012;6(12):e1971 - PubMed
  25. Immunol Lett. 2016 Feb;170:15-26 - PubMed
  26. Med Microbiol Immunol. 2013 Jun;202(3):197-206 - PubMed
  27. Thorax. 2012 Jun;67(6):533-9 - PubMed
  28. J Immunol. 2005 Jun 1;174(11):7147-53 - PubMed
  29. J Immunol. 2000 Jul 1;165(1):364-72 - PubMed
  30. Front Immunol. 2012 Mar 21;3:58 - PubMed
  31. Infect Immun. 2004 Mar;72(3):1240-7 - PubMed
  32. J Immunol. 2003 Oct 1;171(7):3705-10 - PubMed
  33. Immunol Rev. 2004 Oct;201:206-24 - PubMed
  34. J Cell Biochem. 1999 Mar 15;72(4):570-85 - PubMed
  35. Nature. 2001 Apr 5;410(6829):701-5 - PubMed
  36. Mem Inst Oswaldo Cruz. 2007 Feb;102(1):79-82 - PubMed
  37. Stem Cells Transl Med. 2017 Jun;6(6):1557-1567 - PubMed
  38. PLoS Negl Trop Dis. 2015 Aug 06;9(8):e0003945 - PubMed
  39. Pathog Glob Health. 2016 Sep;110(6):247-260 - PubMed
  40. J Cell Biochem. 2017 Sep;118(9):2764-2779 - PubMed
  41. Respir Res. 2014 Oct 03;15:118 - PubMed
  42. World J Stem Cells. 2015 Mar 26;7(2):368-79 - PubMed
  43. Mem Inst Oswaldo Cruz. 2004 May;99(3):239-51 - PubMed

Publication Types